Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Maxwell

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Cytokine|March 2, 1999
An interluekin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathyB V Loughrey, A P Maxwell, D G Fogarty, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 22, 2008
No support for association of protein kinase C, beta 1 (PRKCB1) gene promoter polymorphisms c.-1504C>T and c.-546C>G with diabetic nephropathy in Type 1 diabetesK A Pettigrew, A J McKnight, R J Martin, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 31, 2015
Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetesE J Swan, R M Salem, N Sandholm, et al.
Journal of Child Neurology|August 2, 2000
Short-term benefit from oral vancomycin treatment of regressive-onset autismR H Sandler, S M Finegold, E R Bolte, et al.
Kidney International|July 20, 1999
Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipientsO Hasselwander, D A Savage, D McMaster, et al.
British Journal of Haematology|April 12, 2001
Characterization and localization of expression of an erythropoietin-induced gene, ERIC-1/TACC3, identified in erythroid precursor cellsP J McKeveney, V M Hodges, R N Mullan, et al.
Clinical Nephrology|June 5, 2007
The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II studyR Provenzano, A Besarab, I C Macdougall, et al.
BMC Neurology|March 12, 2021
Retinal microvascular parameters are not significantly associated with mild cognitive impairment in the Northern Ireland Cohort for the Longitudinal Study of AgeingR A O'Neill, A P Maxwell, E N Paterson, et al.
American Journal of Nephrology|October 22, 2010
Genetic polymorphisms in nitric oxide synthase 3 gene and implications for kidney disease: a meta-analysisA J McKnight, C C Patterson, N Sandholm, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 10, 2013
Chronic kidney disease and diabetes in the national health service: a cross-sectional survey of the U.K. national diabetes auditC J Hill, C R Cardwell, C C Patterson, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Cytokine|March 2, 1999
An interluekin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathyB V Loughrey, A P Maxwell, D G Fogarty, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 22, 2008
No support for association of protein kinase C, beta 1 (PRKCB1) gene promoter polymorphisms c.-1504C>T and c.-546C>G with diabetic nephropathy in Type 1 diabetesK A Pettigrew, A J McKnight, R J Martin, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 31, 2015
Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetesE J Swan, R M Salem, N Sandholm, et al.
Journal of Child Neurology|August 2, 2000
Short-term benefit from oral vancomycin treatment of regressive-onset autismR H Sandler, S M Finegold, E R Bolte, et al.
Kidney International|July 20, 1999
Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipientsO Hasselwander, D A Savage, D McMaster, et al.
British Journal of Haematology|April 12, 2001
Characterization and localization of expression of an erythropoietin-induced gene, ERIC-1/TACC3, identified in erythroid precursor cellsP J McKeveney, V M Hodges, R N Mullan, et al.
Clinical Nephrology|June 5, 2007
The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II studyR Provenzano, A Besarab, I C Macdougall, et al.
BMC Neurology|March 12, 2021
Retinal microvascular parameters are not significantly associated with mild cognitive impairment in the Northern Ireland Cohort for the Longitudinal Study of AgeingR A O'Neill, A P Maxwell, E N Paterson, et al.
American Journal of Nephrology|October 22, 2010
Genetic polymorphisms in nitric oxide synthase 3 gene and implications for kidney disease: a meta-analysisA J McKnight, C C Patterson, N Sandholm, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 10, 2013
Chronic kidney disease and diabetes in the national health service: a cross-sectional survey of the U.K. national diabetes auditC J Hill, C R Cardwell, C C Patterson, et al.
Pageof 10